Cell Cycle 2009-06-15

A novel mode of FoxM1 regulation: positive auto-regulatory loop.

Marianna Halasi, Andrei L Gartel

Index: Cell Cycle 8(12) , 1966-7, (2009)

Full Text: HTML

Abstract

Oncogenic transcription factor FoxM1 represents an attractive therapeutic target in the fight against cancer, because it is overexpressed in a majority of human tumors. Previously, we identified the thiazole antibiotics as potent inhibitors of FoxM1. Surprisingly, investigation of the mechanism of action of FoxM1 inhibitors revealed a novel mode of positive auto-regulation of FoxM1.

Related Compounds

  • Siomycin A

Related Articles:

Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.

2009-01-01

[PLoS ONE 4(5) , e5592, (2009)]

The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.

2013-02-01

[J. Mol. Med. 91(2) , 237-48, (2013)]

Two-dimensional NMR spectroscopy of siomycin A. Proton--carbon-13 chemical shift correlation.

1982-03-01

[Eur. J. Biochem. 123(1) , 127-31, (1982)]

FOXM1: the Achilles' heel of cancer?

2008-02-01

[Nat. Rev. Cancer 8(3) , c1; author reply c2, (2008)]

Future roles for FoxM1 inhibitors in cancer treatments.

2007-02-01

[Future Oncol. 3(1) , 1-3, (2007)]

More Articles...